Many prostate cancer patients — and particularly those who don’t like the idea of prostate biopsies — think that if one uses MRI-guided biopsies alone one might only need to have one or two biopsy cores taken to accurately diagnose prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, cores, fusion, MRI, MRI/TRUS, number, scan | 7 Comments »
A new article in the September issue of Prostate addresses the potential benefits of “extreme apical sampling” during the initial biopsies of men at risk for prostate cancer based on such standard parameters as PSA level, positive/negative DRE, and related factors. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: apex, benefit, biopsy, cores, number, risk | 3 Comments »
Not surprisingly, a major urology organization (the Large Urology Group Practice Association or LUGPA) has aggressively disputed the findings recently published by Mitchell in Health Affairs regarding the numbers of prostate biopsies conducted by urology groups with in-house pathology laboratories (see earlier commentary). … READ MORE …
Filed under: Uncategorized | Tagged: biopsy, cores, prostate | 2 Comments »
In recent years it has become increasingly widely accepted that clinical stage is of dubious value as a prognostic factor in determining prostate cancer risk, particularly as regards the sub-stages of clinical stage T2 (i.e., T2a, T2b, and T2c) in men with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biopsy, cores, localized, positive, PPC, staging | 10 Comments »
The current report offers a revised and updated commentary on the paper by Abd et al., first referred to yesterday on this blog. We have now had the opportunity to read the entire paper. While it does not change the general tenor of our prior comments, it is useful to make sure one has all relevant information on a topic this important. … READ MORE …
Filed under: Diagnosis | Tagged: biopsy, cores, Diagnosis, number, positive, veteran | Leave a comment »
Back in the 1990s, it became customary to carry out prostate cancer biopsies under transrectal ultrasound (TRUS) guidance using the so-called “sextant” approach, under which six preplanned biopsy cores were taken from each of six specific areas of the prostate. … READ MORE …
Filed under: Diagnosis | Tagged: biopsy, cores, number, outcome | 1 Comment »
This weekend’s news report includes items on:
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surviellance, biopsy, cores, focal therapy, progression, PSA, radical prostatectomy, ultrasensitive | Leave a comment »
